Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

gerjan navis

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Anatomy

Chemicals & Drugs

Disorders

Physiology

Glomerular Filtration Rate

Living Beings

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Muntinghe Friso L H; Gross Sascha; Bakker Stephan J L; Landman Gijs W D; van der Harst Pim; Bilo Henk J G; Navis Gerjan; Zuurman Mike W
CCR5Delta32 genotype is associated with outcome in type 2 diabetes mellitus.
Krikken Jan A; Laverman Gozewijn D; Navis Gerjan
Benefits of dietary sodium restriction in the management of chronic kidney disease.
Bakker S J L; Navis G; Gans R O B
Copper chelation as a potential treatment for left-ventricular hypertrophy in type 2 diabetes.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of gerjan navis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Muntinghe Friso L H; Gross Sascha; Bakker Stephan J L; Landman Gijs W D; van der Harst Pim; Bilo Henk J G; Navis Gerjan; Zuurman Mike W
CCR5Delta32 genotype is associated with outcome in type 2 diabetes mellitus.
Diabetes research and clinical practice 2009;86(2):140-5.
2009: Krikken Jan A; Laverman Gozewijn D; Navis Gerjan
Benefits of dietary sodium restriction in the management of chronic kidney disease.
Current opinion in nephrology and hypertension 2009;18(6):531-8.
2009: Bakker S J L; Navis G; Gans R O B
Copper chelation as a potential treatment for left-ventricular hypertrophy in type 2 diabetes.
Diabetologia 2009;52(10):2244.
2009: Vegter Stefan; Perna Annalisa; Hiddema Wâtse; Ruggenenti Piero; Remuzzi Giuseppe; Navis Gerjan; Postma Maarten J
Cost-effectiveness of ACE inhibitor therapy to prevent dialysis in nondiabetic nephropathy: influence of the ACE insertion/deletion polymorphism.
Pharmacogenetics and genomics 2009;19(9):695-703.
2009: Damman Kevin; Jaarsma Tiny; Voors Adriaan A; Navis Gerjan; Hillege Hans L; van Veldhuisen Dirk J;
Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH).
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2009;11(9):847-54.
2009: van den Hoven Mabel J; Waanders Femke; Rops Angelique L; Kramer Andrea B; van Goor Harry; Berden Jo H; Navis Gerjan; van der Vlag Johan
Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24(9):2637-45.
2009: van Ree Rutger M; de Vries Aiko P J; Oterdoom Leendert H; Seelen Marc A; Gansevoort Ron T; Schouten Jan P; Struck Joachim; Navis Gerjan; Gans Reinold O B; van der Heide Jaap J Homan; van Son Willem J; Bakker Stephan J L
Plasma procalcitonin is an independent predictor of graft failure late after renal transplantation.
Transplantation 2009;88(2):279-87.
2009: Linssen Gerard C M; Damman Kevin; Hillege Hans L; Navis Gerjan; van Veldhuisen Dirk J; Voors Adriaan A
Urinary N-terminal prohormone brain natriuretic peptide excretion in patients with chronic heart failure.
Circulation 2009;120(1):35-41.
2009: Muntinghe Friso L H; Verduijn Marion; Zuurman Mike W; Grootendorst Diana C; Carrero Juan Jesus; Qureshi Abdul Rashid; Luttropp Karin; Nordfors Louise; Lindholm Bengt; Brandenburg Vincent; Schalling Martin; Stenvinkel Peter; Boeschoten Elisabeth W; Krediet Raymond T; Navis Gerjan; Dekker Friedo W
CCR5 deletion protects against inflammation-associated mortality in dialysis patients.
Journal of the American Society of Nephrology : JASN 2009;20(7):1641-9.
2009: Bakker Winston W; Henning Rob H; van Son Willem J; van Pampus Maria G; Aarnoudse Jan G; Niezen-Koning Klary E; Borghuis Theo; Jongman Rianne M; van Goor Harry; Poelstra Klaas; Navis Gerjan; Faas Marijke M
Vascular contraction and preeclampsia: downregulation of the Angiotensin receptor 1 by hemopexin in vitro.
Hypertension 2009;53(6):959-64.
2009: Oterdoom Leendert H; de Vries Aiko P J; van Ree Rutger M; Gansevoort Ron T; van Son Willem J; van der Heide Jaap J Homan; Navis Gerjan; de Jong Paul E; Gans Reinold O B; Bakker Stephan J L
N-terminal pro-B-type natriuretic peptide and mortality in renal transplant recipients versus the general population.
Transplantation 2009;87(10):1562-70.
2009: Mahmoodi Bakhtawar K; Gansevoort Ron T; Veeger Nic J G M; Matthews Abigail G; Navis Gerjan; Hillege Hans L; van der Meer Jan;
Microalbuminuria and risk of venous thromboembolism.
JAMA : the journal of the American Medical Association 2009;301(17):1790-7.
2009: Waanders Femke; Rienstra Heleen; Boer Mark Walther; Zandvoort André; Rozing Jan; Navis Gerjan; van Goor Harry; Hillebrands Jan-Luuk
Spironolactone ameliorates transplant vasculopathy in renal chronic transplant dysfunction in rats.
American journal of physiology. Renal physiology 2009;296(5):F1072-9.
2009: Kramer Andrea B; van Timmeren Mirjan M; Schuurs Theo A; Vaidya Vishal S; Bonventre Joseph V; van Goor Harry; Navis Gerjan
Reduction of proteinuria in adriamycin-induced nephropathy is associated with reduction of renal kidney injury molecule (Kim-1) over time.
American journal of physiology. Renal physiology 2009;296(5):F1136-45.
2009: Vogt Liffert; de Zeeuw Dick; Woittiez Arend Jan J; Navis Gerjan
Selective cyclooxygenase-2 (COX-2) inhibition reduces proteinuria in renal patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24(4):1182-9.
2009: Damman Kevin; van Deursen Vincent M; Navis Gerjan; Voors Adriaan A; van Veldhuisen Dirk J; Hillege Hans L
Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease.
Journal of the American College of Cardiology 2009;53(7):582-8.
2009: Smilde Tom D J; Damman Kevin; van der Harst Pim; Navis Gerjan; Daan Westenbrink B; Voors Adriaan A; Boomsma Frans; van Veldhuisen Dirk J; Hillege Hans L
Differential associations between renal function and "modifiable" risk factors in patients with chronic heart failure.
Clinical research in cardiology : official journal of the German Cardiac Society 2009;98(2):121-9.
2009: Westendorp Bart; Hamming Inge; Szymanski Mariusz K; Navis Gerjan; van Goor Harry; Buikema Hendrik; van Gilst Wiek H; Schoemaker Regien G
Adverse renal effects of hydrochlorothiazide in rats with myocardial infarction treated with an ACE inhibitor.
European journal of pharmacology 2009;602(2-3):373-9.
2009: Ulu Nadir; Schoemaker Regien G; Henning Robert H; Buikema Hendrik; Teerlink Tom; Zijlstra Freek J; Bakker Stephan J L; van Gilst Wiek H; Navis Gerjan
Proteinuria-associated endothelial dysfunction is strain dependent.
American journal of nephrology 2009;30(3):209-17.
2009: Broekema Martine; Harmsen Martin C; Koerts Jasper A; van Kooten Theo G; Uges Donald R A; Petersen Arjen H; van Luyn Marja J A; Navis Gerjan; Popa Eliane R
Ciclosporin does not influence bone marrow-derived cell differentiation to myofibroblasts early after renal ischemia/reperfusion.
American journal of nephrology 2009;30(1):73-83.
2008: Bakker Stephan J L; Alkhalaf Alaa; Tarnow Lise; Navis Gerjan
Re: Exclusion of polymorphisms in carnosinase genes (CNDP1 and CNDP2) as a cause of diabetic nephropathy in type 1 diabetes: results of large case-control and follow-up studies.
Diabetes 2008;57(12):e16; author reply e17.
2008: de Jong Paul E; Navis Gerjan
Proteinuria lowering needs a multifactorial and individualized approach to halt progression of renal disease.
Nature clinical practice. Nephrology 2008;4(12):654-5.
2008: Krikken Jan A; Dallinga-Thie Geesje M; Navis Gerjan; Dullaart Robin P F
Renin-angiotensin-aldosterone responsiveness to low sodium and blood pressure reactivity to angiotensin-II are unrelated to cholesteryl ester transfer protein mass in healthy subjects.
Expert opinion on therapeutic targets 2008;12(11):1321-8.
2008: Damman Kevin; van Veldhuisen Dirk J; Navis Gerjan; Voors Adriaan A; Hillege Hans L
Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2008;10(10):997-1000.
2008: Rook M; Bosma R J; van Son W J; Hofker H S; van der Heide J J Homan; ter Wee P M; Ploeg R J; Navis G J
Nephrectomy elicits impact of age and BMI on renal hemodynamics: lower postdonation reserve capacity in older or overweight kidney donors.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2008;8(10):2077-85.
2008: Slagman M C J; Waanders F; Navis G J
[No advantage of the combination of ACE-inhibition and angiotensin receptor blockade in patients with high cardiovascular risk]
Nederlands tijdschrift voor geneeskunde 2008;152(39):2150-1; author reply 2151.
2008: Visser Folkert W; Muntinga Jaap H J; Dierckx Rudi A; Navis Gerjan
Feasibility and impact of the measurement of extracellular fluid volume simultaneous with GFR by 125I-iothalamate.
Clinical journal of the American Society of Nephrology : CJASN 2008;3(5):1308-15.
2008: Oterdoom Leendert H; van Ree Rutger M; de Vries Aiko P J; Gansevoort Ron T; Schouten Jan P; van Son Willem J; Homan van der Heide Jaap J; Navis Gerjan; de Jong Paul E; Gans Reinold O B; Bakker Stephan J L
Urinary creatinine excretion reflecting muscle mass is a predictor of mortality and graft loss in renal transplant recipients.
Transplantation 2008;86(3):391-8.
2008: Kuipers Irma; van der Harst Pim; Navis Gerjan; van Genne Linda; Morello Fulvio; van Gilst Wiek H; van Veldhuisen Dirk J; de Boer Rudolf A
Nuclear hormone receptors as regulators of the renin-angiotensin-aldosterone system.
Hypertension 2008;51(6):1442-8.
2008: Loef B G; Henning R H; Navis G; Rankin A J; van Oeveren W; Ebels T; Epema A H
Changes in glomerular filtration rate after cardiac surgery with cardiopulmonary bypass in patients with mild preoperative renal dysfunction.
British journal of anaesthesia 2008;100(6):759-64.
2008: Ulu Nadir; Buikema Hendrik; van Gilst Wiek H; Navis Gerjan
Vascular dysfunction in adriamycin nephrosis: different effects of adriamycin exposure and nephrosis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(6):1854-60.
2008: Doorenbos Carolien; Tsaih Shirng-Wern; Sheehan Susan; Ishimori Naoki; Navis Gerjan; Churchill Gary; Dipetrillo Keith; Korstanje Ron
Quantitative trait loci for urinary albumin in crosses between C57BL/6J and A/J inbred mice in the presence and absence of Apoe.
Genetics 2008;179(1):693-9.
2008: Vogt Liffert; Waanders Femke; Boomsma Frans; de Zeeuw Dick; Navis Gerjan
Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan.
Journal of the American Society of Nephrology : JASN 2008;19(5):999-1007.
2008: Hamming I; van Goor H; Turner A J; Rushworth C A; Michaud A A; Corvol P; Navis G
Differential regulation of renal angiotensin-converting enzyme (ACE) and ACE2 during ACE inhibition and dietary sodium restriction in healthy rats.
Experimental physiology 2008;93(5):631-8.
2008: Liu Yan; van Goor Harry; Havinga Rick; Baller Julius F W; Bloks Vincent W; van der Leij Feike R; Sauer Pieter J J; Kuipers Folkert; Navis Gerjan; de Borst Martin H
Neonatal dexamethasone administration causes progressive renal damage due to induction of an early inflammatory response.
American journal of physiology. Renal physiology 2008;294(4):F768-76.
2008: Krikken J A; Bosma R J; Navis G J
[Overweight and mortality risk: no connection between overweight in middle and older age groups and increased mortality]
Nederlands tijdschrift voor geneeskunde 2008;152(11):654-5; author reply 655.
2008: Visser Folkert W; Boonstra Arnold H; Titia Lely A; Boomsma Frans; Navis Gerjan
Renal response to angiotensin II is blunted in sodium-sensitive normotensive men.
American journal of hypertension 2008;21(3):323-8.
2008: Onuta Geanina; Hillebrands Jan-Luuk; Rienstra Heleen; Boer Mark Walther; Klatter Flip A; Navis Gerjan; Rozing Jan; Roks Anton J M
Dichotomous effects of rosiglitazone in transplantation-induced systemic vasodilator dysfunction in rats.
Transplantation 2008;85(4):582-8.
2008: Waanders Femke; van den Berg Else; Nagai Ryoji; van Veen Ingrid; Navis Gerjan; van Goor Harry
Renoprotective effects of the AGE-inhibitor pyridoxamine in experimental chronic allograft nephropathy in rats.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(2):518-24.
2008: Mahmoodi Bakhtawar K; ten Kate Min Ki; Waanders Femke; Veeger Nic J G M; Brouwer Jan-Leendert P; Vogt Liffert; Navis Gerjan; van der Meer Jan
High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study.
Circulation 2008;117(2):224-30.
2008: Lely A Titia; van der Kleij Frank G H; Kistemaker Taco J; Apperloo Alfred J; de Jong Paul E; de Zeeuw Dick; Navis Gerjan
Impact of the preintervention rate of renal function decline on outcome of renoprotective intervention.
Clinical journal of the American Society of Nephrology : CJASN 2008;3(1):54-60.
2008: Waanders Femke; van Goor Harry; Navis Gerjan
Adverse renal effects of the AGE inhibitor pyridoxamine in combination with ACEi in non-diabetic adriamycin-induced renal damage in rats.
Kidney & blood pressure research 2008;31(5):350-9.
2008: Vegter Stefan; Boersma Cornelis; Rozenbaum Mark; Wilffert Bob; Navis Gerjan; Postma Maarten J
Pharmacoeconomic evaluations of pharmacogenetic and genomic screening programmes: a systematic review on content and adherence to guidelines.
PharmacoEconomics 2008;26(7):569-87.
2008: Stolk Ronald P; Rosmalen Judith G M; Postma Dirkje S; de Boer Rudolf A; Navis Gerjan; Slaets Joris P J; Ormel Johan; Wolffenbuttel Bruce H R
Universal risk factors for multifactorial diseases: LifeLines: a three-generation population-based study.
European journal of epidemiology 2008;23(1):67-74.
2007: Asselbergs Folkert W; Williams Scott M; Hebert Patricia R; Coffey Christopher S; Hillege Hans L; Snieder Harold; Navis Gerjan; Vaughan Douglas E; van Gilst Wiek H; Moore Jason H
The effects of polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels are dependent on environmental context.
Human genetics 2007;122(3-4):275-81.
2007: Broekema Martine; Harmsen Martin C; Koerts Jasper A; van Kooten Theo G; Navis Gerjan; van Luyn Marja J A; Popa Eliane R
Tubular engraftment and myofibroblast differentiation of recipient-derived cells after experimental kidney transplantation.
Transplantation 2007;84(8):1003-11.
2007: Damman Kevin; Navis Gerjan; Voors Adriaan A; Asselbergs Folkert W; Smilde Tom D J; Cleland John G F; van Veldhuisen Dirk J; Hillege Hans L
Worsening renal function and prognosis in heart failure: systematic review and meta-analysis.
Journal of cardiac failure 2007;13(8):599-608.
2007: Smilde Tom D J; Zuurman Mike W; Hillege Hans L; van Veldhuisen Dirk J; van Gilst Wiek H; van der Steege Gerrit; Voors Adriaan A; Kors Jan A; de Jong Paul E; Navis Gerjan
Renal function dependent association of AGTR1 polymorphism (A1166C) and electrocardiographic left-ventricular hypertrophy.
American journal of hypertension 2007;20(10):1097-103.
2007: De Borst M H; Prakash J; Melenhorst W B W H; van den Heuvel M C; Kok R J; Navis G; van Goor H
Glomerular and tubular induction of the transcription factor c-Jun in human renal disease.
The Journal of pathology 2007;213(2):219-28.
2007: Waanders Femke; van den Berg Else; Schalkwijk Casper; van Goor Harry; Navis Gerjan
Preparation of advanced glycation end products in vitro.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(10):3093-4.
2007: Wijnhoven Tessa J M; Geelen Joyce M; Bakker Marinka; Lensen Joost F M; Rops Angelique L W M M; Kramer Andrea B; Navis Gerjan; van den Hoven Mabel J W; van der Vlag Johan; Berden Jo H M; Wetzels Jack F M; van den Heuvel Lambert P W J; Monnens Leo A H; van Kuppevelt Toin H
Adult and paediatric patients with minimal change nephrotic syndrome show no major alterations in glomerular expression of sulphated heparan sulphate domains.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(10):2886-93.
2007: Gross Sascha; van Ree Rutger M; Oterdoom Leendert H; de Vries Aiko P J; van Son Willem J; de Jong Paul E; Navis Gerjan J; Zuurman Mike W; Bierhaus Angelika; Gans Rijk O B; Bakker Stephan J L
Low levels of sRAGE are associated with increased risk for mortality in renal transplant recipients.
Transplantation 2007;84(5):659-63.
2007: Damman Kevin; Navis Gerjan; Smilde Tom D J; Voors Adriaan A; van der Bij Wim; van Veldhuisen Dirk J; Hillege Hans L
Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2007;9(9):872-8.
2007: Navis G J
[Renal function assessment]
Nederlands tijdschrift voor geneeskunde 2007;151(31):1758-9; author reply 1759.
2007: Onuta Geanina; Rienstra Heleen; de Boer Jan Freark; Boer Mark Walther; Roks Anton J M; Klatter Flip A; Uges Donald R A; Navis Gerjan; Rozing Jan; Hillebrands Jan-Luuk
Rosiglitazone attenuates transplant arteriosclerosis after allogeneic aorta transplantation in rats.
Transplantation 2007;84(4):517-26.
2007: de Borst Martin H; Diks Sander H; Bolbrinker Juliane; Schellings Mark W; van Dalen Mario B A; Peppelenbosch Maikel P; Kreutz Reinhold; Pinto Yigal M; Navis Gerjan; van Goor Harry
Profiling of the renal kinome: a novel tool to identify protein kinases involved in angiotensin II-dependent hypertensive renal damage.
American journal of physiology. Renal physiology 2007;293(1):F428-37.
2007: Hamming I; Cooper M E; Haagmans B L; Hooper N M; Korstanje R; Osterhaus A D M E; Timens W; Turner A J; Navis G; van Goor H
The emerging role of ACE2 in physiology and disease.
The Journal of pathology 2007;212(1):1-11.
2007: Lely A Titia; Krikken Jan A; Bakker Stephan J L; Boomsma Frans; Dullaart Robin P F; Wolffenbuttel Bruce H R; Navis Gerjan
Low dietary sodium and exogenous angiotensin II infusion decrease plasma adiponectin concentrations in healthy men.
The Journal of clinical endocrinology and metabolism 2007;92(5):1821-6.
2007: Mui Kwok-Wai; Woittiez Arend-Jan; Navis Gerjan
Atherosclerotic renovascular disease and renal impairment: can we predict the effect of intervention?
Current hypertension reports 2007;9(2):140-7.
2007: Bosma R J; Kwakernaak A J; van der Heide J J Homan; de Jong P E; Navis G J
Body mass index and glomerular hyperfiltration in renal transplant recipients: cross-sectional analysis and long-term impact.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(3):645-52.
2007: Kramer A B; van der Meulen E F; Hamming I; van Goor H; Navis G
Effect of combining ACE inhibition with aldosterone blockade on proteinuria and renal damage in experimental nephrosis.
Kidney international 2007;71(5):417-24.
2007: Asselbergs Folkert W; Williams Scott M; Hebert Patricia R; Coffey Christopher S; Hillege Hans L; Navis Gerjan; Vaughan Douglas E; van Gilst Wiek H; Moore Jason H
Epistatic effects of polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels.
Genomics 2007;89(3):362-9.
2007: Lely A Titia; Luik Peter T; Navis Gerjan
Angiotensin I-converting enzyme: a pathogenetic role in diabetic renal damage?
Current diabetes reviews 2007;3(1):41-52.
2007: Asselbergs F W; Williams S M; Hebert P R; Coffey C S; Hillege H L; Navis G; Vaughan D E; van Gilst W H; Moore J H
Gender-specific correlations of plasminogen activator inhibitor-1 and tissue plasminogen activator levels with cardiovascular disease-related traits.
Journal of thrombosis and haemostasis : JTH 2007;5(2):313-20.
2007: Krikken J A; Lely A T; Bakker S J L; Navis G
The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men.
Kidney international 2007;71(3):260-5.
2007: Westenbrink B Daan; Visser Folkert W; Voors Adriaan A; Smilde Tom D J; Lipsic Erik; Navis Gerjan; Hillege Hans L; van Gilst Wiek H; van Veldhuisen Dirk J
Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well.
European heart journal 2007;28(2):166-71.
2007: Broekema Martine; Harmsen Martin C; van Luyn Marja J A; Koerts Jasper A; Petersen Arjen H; van Kooten Theo G; van Goor Harry; Navis Gerjan; Popa Eliane R
Bone marrow-derived myofibroblasts contribute to the renal interstitial myofibroblast population and produce procollagen I after ischemia/reperfusion in rats.
Journal of the American Society of Nephrology : JASN 2007;18(1):165-75.
2007: Rook Mieneke; van der Heide Jaap J Homan; Navis Gerjan
Significant negative association with age and both GFR and ERPF in male and female living kidney donors.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(1):283; author reply 284.
2007: de Borst Martin H; van Timmeren Mirjan M; Vaidya Vishal S; de Boer Rudolf A; van Dalen Mario B A; Kramer Andrea B; Schuurs Theo A; Bonventre Joseph V; Navis Gerjan; van Goor Harry
Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase.
American journal of physiology. Renal physiology 2007;292(1):F313-20.
2007: Bakker Winston W; Donker Rogier B; Timmer Albertus; van Pampus Mariëlle G; van Son Willem J; Aarnoudse Jan G; van Goor Harry; Niezen-Koning Klary E; Navis Gerjan; Borghuis Theo; Jongman Rianne M; Faas Marijke M
Plasma hemopexin activity in pregnancy and preeclampsia.
Hypertension in pregnancy : official journal of the International Society for the Study of Hypertension in Pregnancy 2007;26(2):227-39.
2006: Smilde Tom D J; van Veldhuisen Dirk J; Navis Gerjan; Voors Adriaan A; Hillege Hans L
Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction.
Circulation 2006;114(15):1572-80.
2006: Asselbergs Folkert W; Williams Scott M; Hebert Patricia R; Coffey Christopher S; Hillege Hans L; Navis Gerjan; Vaughan Douglas E; van Gilst Wiek H; Moore Jason H
The gender-specific role of polymorphisms from the fibrinolytic, renin-angiotensin, and bradykinin systems in determining plasma t-PA and PAI-1 levels.
Thrombosis and haemostasis 2006;96(4):471-7.
2006: Hamming I; Goor H van; Navis G J
ACE inhibitor use and the increased long-term risk of renal failure in diabetes.
Kidney international 2006;70(7):1377-8; author reply 1378.
2006: Brenchley Paul E C; Lindholm Bengt; Dekker Friedo W; Navis Gerjan
Translating knowledge of the human genome into clinical practice in nephrology dialysis and transplantation: the renal genome network (ReGeNet).
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(10):2681-3.
2006: Kramer Andrea; van den Hoven Mabel; Rops Angelique; Wijnhoven Tessa; van den Heuvel Lambert; Lensen Joost; van Kuppevelt Toin; van Goor Harry; van der Vlag Johan; Navis Gerjan; Berden Jo H M
Induction of glomerular heparanase expression in rats with adriamycin nephropathy is regulated by reactive oxygen species and the renin-angiotensin system.
Journal of the American Society of Nephrology : JASN 2006;17(9):2513-20.
2006: Rook M; Hofker H S; van Son W J; Homan van der Heide J J; Ploeg R J; Navis G J
Predictive capacity of pre-donation GFR and renal reserve capacity for donor renal function after living kidney donation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2006;6(7):1653-9.
2006: Mui Kwok-Wai; Sleeswijk Mengalvio; van den Hout Huib; van Baal Jef; Navis Gerjan; Woittiez Arend-Jan
Incidental renal artery stenosis is an independent predictor of mortality in patients with peripheral vascular disease.
Journal of the American Society of Nephrology : JASN 2006;17(7):2069-74.
2006: Hamming I; Navis G; Kocks M J A; van Goor H
ACE inhibition has adverse renal effects during dietary sodium restriction in proteinuric and healthy rats.
The Journal of pathology 2006;209(1):129-39.
2006: de Vries A P J; van Son W J; van der Heide J J Homan; Ploeg R J; Navis G; de Jong P E; Gans R O B; Bakker S J L; Gansevoort R T
The predictive value of renal vascular resistance for late renal allograft loss.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2006;6(2):364-70.
2006: Smilde Tom D J; Hillege Hans L; Navis Gerjan; Voors Adriaan A; Brouwer J; van Veldhuisen Dirk J
Difference in long-term prognostic value of renal function between ischemic and non-ischemic mild heart failure.
International journal of cardiology 2006;107(1):73-7.
2006: van der Harst Pim; Smilde Tom D J; Buikema Hendrik; Voors Adriaan A; Navis Gerjan; van Veldhuisen Dirk J; van Gilst Wiek H
Vascular function and mild renal impairment in stable coronary artery disease.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(2):379-84.
2006: Vogt Liffert; Laverman Gozewijn D; van Tol Arie; Groen Albert K; Navis Gerjan; Dullaart Robin P F
Cellular cholesterol efflux to plasma from proteinuric patients is elevated and remains unaffected by antiproteinuric treatment.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(1):101-6.
2006: Bosma R J; Krikken J A; Homan van der Heide J J; de Jong P E; Navis G J
Obesity and renal hemodynamics.
Contributions to nephrology 2006;151():184-202.
2006: Asselbergs Folkert W; Moore Jason H; van den Berg Maarten P; Rimm Eric B; de Boer Rudolf A; Dullaart Robin P; Navis Gerjan; van Gilst Wiek H
A role for CETP TaqIB polymorphism in determining susceptibility to atrial fibrillation: a nested case control study.
BMC medical genetics 2006;7():39.
2006: Kramer Andrea B; Bos Hendrik; van Goor Harry; Navis Gerjan J
Sodium intake modifies the negative prognostic value of renal damage prior to treatment with ACE inhibitors on proteinuria induced by adriamycin.
Nephron. Physiology 2006;103(1):p43-52.
2005: Broekema Martine; Harmsen Martin C; Koerts Jasper A; Petersen Arjen H; van Luyn Marja J A; Navis Gerjan; Popa Eliane R
Determinants of tubular bone marrow-derived cell engraftment after renal ischemia/reperfusion in rats.
Kidney international 2005;68(6):2572-81.
2005: Meerwaldt Robbert; Hartog Jasper W L; Graaff Reindert; Huisman Roel J; Links Thera P; den Hollander Nynke C; Thorpe Susan R; Baynes John W; Navis Gerjan; Gans Rijk O B; Smit Andries J
Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients.
Journal of the American Society of Nephrology : JASN 2005;16(12):3687-93.
2005: Kreutz Reinhold; Zuurman Mike; Kain Silke; Bolbrinker Juliane; de Jong Paul E; Navis Gerjan
The role of the cytochrome P450 3A5 enzyme for blood pressure regulation in the general Caucasian population.
Pharmacogenetics and genomics 2005;15(12):831-7.
2005: Kramer Andrea B; Ricardo Sharon D; Kelly Darren J; Waanders Femke; van Goor Harry; Navis Gerjan
Modulation of osteopontin in proteinuria-induced renal interstitial fibrosis.
The Journal of pathology 2005;207(4):483-92.
2005: van der Sman-de Beer Femke; Verhagen Claudia; Rombach Saskia M; Boorsma Peter; van Manen Jeannette G; Korevaar Johanna C; van den Bogaard Ruud; Boeschoten Elisabeth W; Krediet Raymond T; Navis Gerjan J; Vandenbroucke Jan P; Dekker Friedo W;
ACE I/D polymorphism is associated with mortality in a cohort study of patients starting with dialysis.
Kidney international 2005;68(5):2237-43.
2005: Vogt Liffert; Navis Gerjan; Köster Jürgen; Manolis Athanasios J; Reid John L; de Zeeuw Dick;
The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trial.
Journal of hypertension 2005;23(11):2055-61.
2005: Mui K W; Woittiez A J J; Navis G J
[The guideline 'Diagnosis and treatment of peripheral artery disease of the lower extremities' of The Netherlands Surgical Society]
Nederlands tijdschrift voor geneeskunde 2005;149(42):2375; author reply 2375-6.
2005: Waanders Femke; Greven Wendela L; Baynes John W; Thorpe Suzanne R; Kramer Andrea B; Nagai Ryoji; Sakata Noriyuki; van Goor Harry; Navis Gerjan
Renal accumulation of pentosidine in non-diabetic proteinuria-induced renal damage in rats.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(10):2060-70.
2005: Bosma Renate J; Doorenbos Carolien R C; Stegeman Coen A; van der Heide Jaap J Homan; Navis Gerjan
Predictive performance of renal function equations in renal transplant recipients: an analysis of patient factors in bias.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(9):2193-203.
2005: Greven Wendela L; Waanders Femke; Nagai Ryoji; van den Heuvel Marius C; Navis Gerjan; van Goor Harry
Mesangial accumulation of GA-pyridine, a novel glycolaldehyde-derived AGE, in human renal disease.
Kidney international 2005;68(2):595-602.
2005: Smilde Tom D J; Hillege Hans L; van Veldhuisen Dirk J; Navis Gerjan
Angiotensin-converting enzyme inhibitors and outcome among patients with heart failure and renal insufficiency: need for a prospective study.
Journal of the American College of Cardiology 2005;45(11):1905.
2005: Navis Gerjan
ACE genotype and long-term graft survival after renal transplantation.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(5):1019-20.
2005: Laverman Gozewijn Dirk; Andersen Steen; Rossing Peter; Navis Gerjan; de Zeeuw Dick; Parving Hans-Henrik
Renoprotection with and without blood pressure reduction.
Kidney international. Supplement 2005;(94):S54-9.
2005: Vogt Liffert; Navis Gerjan; de Zeeuw Dick
Individual titration for maximal blockade of the renin-angiotensin system in proteinuric patients: a feasible strategy?
Journal of the American Society of Nephrology : JASN 2005;16 Suppl 1():S53-7.
2005: Kocks Menno J A; Lely A Titia; Boomsma Frans; de Jong Paul E; Navis Gerjan
Sodium status and angiotensin-converting enzyme inhibition: effects on plasma angiotensin-(1-7) in healthy man.
Journal of hypertension 2005;23(3):597-602.
2005: Rook Mieneke; Lely A Titia; Kramer Andrea B; van Goor Harry; Navis Gerjan
Individual differences in renal ACE activity in healthy rats predict susceptibility to adriamycin-induced renal damage.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(1):59-64.
2005: Loef Berthus G; Epema Anne H; Smilde Ton D; Henning Robert H; Ebels Tjark; Navis Gerjan; Stegeman Coen A
Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival.
Journal of the American Society of Nephrology : JASN 2005;16(1):195-200.
2005: Smit-van Oosten Annemieke; Boonstra Arnold H; Navis Gerjan; van Goor Harry; Buikema Hendrik
Reduced cyclooxygenase involvement in vascular endothelial function in rat renal transplantation.
Nephron. Physiology 2005;100(2):p21-30.
2004: Lely A T; Hamming I; van Goor H; Navis G J
Renal ACE2 expression in human kidney disease.
The Journal of pathology 2004;204(5):587-93.
2004: Loef B G; Henning R H; Epema A H; Rietman G W; van Oeveren W; Navis G J; Ebels T
Effect of dexamethasone on perioperative renal function impairment during cardiac surgery with cardiopulmonary bypass.
British journal of anaesthesia 2004;93(6):793-8.
2004: de Vries P A Marcel; de Zeeuw Dick; de Jong Paul E; Navis Gerjan
The abnormal renal vasodilator response to D1-like receptor stimulation in conscious SHR can be normalized by AT1 blockade.
Journal of cardiovascular pharmacology 2004;44(5):571-6.
2004: Vogt L; Kocks M J A; Laverman G D; Navis G
Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Minerva medica 2004;95(5):395-409.
2004: Verhave J C; Hillege H L; Burgerhof J G M; Janssen W M T; Gansevoort R T; Navis G J; de Zeeuw D; de Jong P E;
Sodium intake affects urinary albumin excretion especially in overweight subjects.
Journal of internal medicine 2004;256(4):324-30.
2004: Kocks Menno J A; Gschwend Simone; de Zeeuw Dick; Navis Gerjan; Buikema Hendrik
Low sodium modifies the vascular effects of angiotensin-converting enzyme inhibitor therapy in healthy rats.
The Journal of pharmacology and experimental therapeutics 2004;310(3):1183-9.
2004: Smilde Tom D J; Hillege Hans L; Navis Gerjan; Boomsma Frans; de Zeeuw Dick; van Veldhuisen Dirk J
Impaired renal function in patients with ischemic and nonischemic chronic heart failure: association with neurohormonal activation and survival.
American heart journal 2004;148(1):165-72.
2004: Bosma Renate J; de Jong Paul E; Navis Gerjan
After all those fat years: renal consequences of obesity.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(7):1934.
2004: Hartog Jasper W L; Smit Andries J; van Son Willem J; Navis Gerjan; Gans Reinold O B; Wolffenbuttel Bruce H R; de Jong Paul E
Advanced glycation end products in kidney transplant patients: a putative role in the development of chronic renal transplant dysfunction.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;43(6):966-75.
2004: Kerstens Michiel N; van der Kleij Frank G H; Boonstra Arnold H; Sluiter Wim J; van der Molen Jan C; Navis Gerjan; Dullaart Robin P F
Angiotensin administration stimulates renal 11 beta-hydroxysteroid dehydrogenase activity in healthy men.
Kidney international 2004;65(6):2065-70.
2004: Hamming I; Timens W; Bulthuis M L C; Lely A T; Navis G J; van Goor H
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.
The Journal of pathology 2004;203(2):631-7.
2004: Luik P T; Visser F W; Dullaart R P; Navis G J
[Diabetic nephropathy: the role of blood pressure and extra-cellular volume in its pathogenesis and treatment]
Nederlands tijdschrift voor geneeskunde 2004;148(17):855-6; author reply 856.
2004: Kerstens Michiel N; Navis Gerjan; Dullaart Robin P F
Salt sensitivity and 11beta-hydroxysteroid dehydrogenase type 2 activity.
American journal of hypertension 2004;17(3):283-4.
2004: Bosma Renate J; van der Heide Jaap J Homan; Oosterop Eric J; de Jong Paul E; Navis Gerjan
Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects.
Kidney international 2004;65(1):259-65.
2004: Vogt Liffert; Laverman Gozewijn D; Dullaart Robin P F; Navis Gerjan
Lipid management in the proteinuric patient: do not overlook the importance of proteinuria reduction.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(1):5-8.
2003: de Borst Martin H; Navis Gerjan; de Boer Rudolf A; Huitema Sippie; Vis Lotte M; van Gilst Wiek H; van Goor Harry
Specific MAP-kinase blockade protects against renal damage in homozygous TGR(mRen2)27 rats.
Laboratory investigation; a journal of technical methods and pathology 2003;83(12):1761-70.
2003: Kocks Menno J A; Buikema Hendrik; Gschwend Simone; Boomsma Frans; de Zeeuw Dick; Navis Gerjan
High dietary sodium blunts affects of angiotensin-converting enzyme inhibition on vascular angiotensin I-to-angiotensin II conversion in rats.
Journal of cardiovascular pharmacology 2003;42(5):601-6.
2003: Kerstens Michiel N; van der Kleij Frank G H; Boonstra Arnold H; Sluiter Wim J; Koerts Jan; Navis Gerjan; Dullaart Robin P F
Salt loading affects cortisol metabolism in normotensive subjects: relationships with salt sensitivity.
The Journal of clinical endocrinology and metabolism 2003;88(9):4180-5.
2003: Kramer Andrea B; Laverman Gozewijn D; van Goor Harry; Navis Gerjan
Inter-individual differences in anti-proteinuric response to ACEi in established adriamycin nephrotic rats are predicted by pretreatment renal damage.
The Journal of pathology 2003;201(1):160-7.
2003: Luik P T; Kerstens M N; Hoogenberg K; Navis G J; Dullaart R P F
Low plasma aldosterone despite normal plasma renin activity in uncomplicated type 1 diabetes mellitus: effects of RAAS stimulation.
European journal of clinical investigation 2003;33(9):787-93.
2003: Luik P T; Hoogenberg K; Kerstens M N; Beusekamp B J; De Jong P E; Dullaart R P F; Navis G J
The influence of the ACE ( I/D) polymorphism on systemic and renal vascular responses to angiotensins in normotensive, normoalbuminuric Type 1 diabetes mellitus.
Diabetologia 2003;46(8):1131-9.
2003: Kerstens M N; Luik P T; van der Kleij F G H; Boonstra A H; Breukelman H; Sluiter W J; Navis G J; Dullaart R P F
Decreased cortisol production in male type 1 diabetic patients.
European journal of clinical investigation 2003;33(7):589-94.
2003: Bos Hendrik; Laverman Gozewijn D; Henning Robert H; Tiebosch Anton T M G; de Jong Paul E; de Zeeuw Dick; Navis Gerjan
Involvement of renal ACE activity in proteinuria-associated renal damage in untreated and treated adriamycin nephrotic rats.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2003;4(2):106-12.
2003: Verhave Jacobien C; Hillege Hans L; Burgerhof Johannes G M; Navis Gerjan; de Zeeuw Dick; de Jong Paul E;
Cardiovascular risk factors are differently associated with urinary albumin excretion in men and women.
Journal of the American Society of Nephrology : JASN 2003;14(5):1330-5.
2003: Pinto-Sietsma Sara-Joan; Navis Gerjan; Janssen Wilbert M T; de Zeeuw Dick; Gans Reinhold O B; de Jong Paul E;
A central body fat distribution is related to renal function impairment, even in lean subjects.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;41(4):733-41.
2003: Deelman Leo E; Navis Gerjan; de Boer Erik; Wietses Mirian; de Zeeuw Dick; Henning Robert H
Role of proteinuria in the regulation of renal renin-angiotensin system components in unilateral proteinuric rats.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2003;4(1):38-42.
2003: Vogt Liffert; Laverman Gozewijn D; de Zeeuw Dick; Navis Gerjan
The COOPERATE trial.
Lancet 2003;361(9362):1055-6.
2003: Hillege H L; van Gilst W H; van Veldhuisen D J; Navis G; Grobbee D E; de Graeff P A; de Zeeuw D;
Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial.
European heart journal 2003;24(5):412-20.
2003: Kerstens Michiel N; Navis Gerjan; Dullaart Robin P F
Does a reduced 11 beta HSD type 2 activity contribute to sodium retention in the nephrotic syndrome?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18(3):620; author reply 620-1.
2003: Laverman Gozewijn D; Van Goor Harry; Henning Robert H; De Jong Paul E; De Zeeuw Dick; Navis Gerjan
Renoprotective effects of VPI versus ACEI in normotensive nephrotic rats on different sodium intakes.
Kidney international 2003;63(1):64-71.
2002: Laverman Gozewijn D; de Zeeuw Dick; Navis Gerjan
Between-patient differences in the renal response to renin-angiotensin system intervention: clue to optimising renoprotective therapy?
Journal of the renin-angiotensin-aldosterone system : JRAAS 2002;3(4):205-13.
2002: Gschwend Simone; Buikema Hendrik; Navis Gerjan; Henning Robert H; de Zeeuw Dick; van Dokkum Richard P E
Endothelial dilatory function predicts individual susceptibility to renal damage in the 5/6 nephrectomized rat.
Journal of the American Society of Nephrology : JASN 2002;13(12):2909-15.
2002: Vogt Liffert; Navis Gerjan; de Zeeuw Dick
Renoprotection: a matter of blood pressure reduction or agent-characteristics?
Journal of the American Society of Nephrology : JASN 2002;13 Suppl 3():S202-7.
2002: Navis Gerjan; Kramer Andrea B; de Jong Paul E
High-dose ACE inhibition: can it improve renoprotection?
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;40(3):664-6.
2002: Laverman Gozewijn D; Navis Gerjan; Henning Robert H; de Jong Paul E; de Zeeuw Dick
Dual renin-angiotensin system blockade at optimal doses for proteinuria.
Kidney international 2002;62(3):1020-5.
2002: Haverdings R Folgert G; Haas Marijke; Navis Gerjan; Van Loenen-Weemaes Anne-Miek; Meijer Dirk K F; De Zeeuw Dick; Moolenaar Frits
Renal targeting of captopril selectively enhances the intrarenal over the systemic effects of ACE inhibition in rats.
British journal of pharmacology 2002;136(8):1107-16.
2002: Kerstens M N; Buter H; Navis G J; Dullaart R P F
11beta-hydroxysteroid dehydrogenase activity in proteinuric patients and the effect of angiotensin-II receptor blockade.
European journal of clinical investigation 2002;32(7):513-8.
2002: Marcel de Vries P A; de Jong Paul E; de Zeeuw D; Navis G J
D2 -like receptor stimulation decreases effective renal plasma flow and glomerular filtration rate in spontaneously hypertensive rats.
Journal of cardiovascular pharmacology 2002;40(1):35-42.
2002: Roeloffzen W W H; Hospers G A P; De Vries E G E; Navis G J
Renal failure after treatment with interferon alpha 2b.
Anticancer research 2002;22(3):1929-31.
2002: Bos Hendrik; Henning Robert H; De Jong Paul E; De Zeeuw Dick; Navis Gerjan
Do severe systemic sequelae of proteinuria modulate the antiproteinuric response to chronic ACE inhibition?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17(5):793-7.
2002: Luik P T; Hoogenberg K; Van Der Kleij F G H; Beusekamp B J; Kerstens M N; De Jong P E; Dullaart R P F; Navis G J
Short-term moderate sodium restriction induces relative hyperfiltration in normotensive normoalbuminuric Type I diabetes mellitus.
Diabetologia 2002;45(4):535-41.
2002: Loef Berthus G; Epema Anne H; Navis Gerjan; Ebels Tjark; van Oeveren Wim; Henning Robbert H
Off-pump coronary revascularization attenuates transient renal damage compared with on-pump coronary revascularization.
Chest 2002;121(4):1190-4.
2002: van der Kleij Frank G H; de Jong Paul E; Henning Rob H; de Zeeuw Dick; Navis Gerjan
Enhanced responses of blood pressure, renal function, and aldosterone to angiotensin I in the DD genotype are blunted by low sodium intake.
Journal of the American Society of Nephrology : JASN 2002;13(4):1025-33.
2002: Kocks Menno J A; de Zeeuw Dick; Navis Gerjan J
Optimal blood pressure control and antihypertensive regimens in hypertensive renal disease: the potential of exploring the mechanisms of response variability.
Current opinion in nephrology and hypertension 2002;11(2):135-40.
2002: Bos Hendrik; Henning Robert H; De Boer Eric; Tiebosch Anton T M G; De Jong Paul E; De Zeeuw Dick; Navis Gerjan
Addition of AT1 blocker fails to overcome resistance to ACE inhibition in adriamycin nephrosis.
Kidney international 2002;61(2):473-80.
2001: Laverman G D; Henning R H; de Jong P E; Navis G; de Zeeuw D
Optimal antiproteinuric dose of losartan in nondiabetic patients with nephrotic range proteinuria.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;38(6):1381-4.
2001: Boonstra A; de Zeeuw D; de Jong P E; Navis G
Role of genetic variability in the renin-angiotensin system in diabetic and nondiabetic renal disease.
Seminars in nephrology 2001;21(6):580-92.
2001: Boonstra A H; Gschwend S; Kocks M J; Buikema H; de Zeeuw D; Navis G J
Does a low-salt diet exert a protective effect on endothelial function in normal rats?
The Journal of laboratory and clinical medicine 2001;138(3):200-5.
2001: Smit-van Oosten A; Navis G; Stegeman C A; Joles J A; Klok P A; Kuipers F; Tiebosch A T; van Goor H
Chronic blockade of angiotensin II action prevents glomerulosclerosis, but induces graft vasculopathy in experimental kidney transplantation.
The Journal of pathology 2001;194(1):122-9.
2001: Buter H; Navis G; Dullaart R P; de Zeeuw D; de Jong P E
Time course of the antiproteinuric and renal haemodynamic responses to losartan in microalbuminuric IDDM.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16(4):771-5.
2001: Wapstra F H; Navis G J; van Goor H; van den Born J; Berden J H; de Jong P E; de Zeeuw D
ACE inhibition preserves heparan sulfate proteoglycans in the glomerular basement membrane of rats with established adriamycin nephropathy.
Experimental nephrology 2001;9(1):21-7.
2000: Pinto-Sietsma S J; Janssen W M; Hillege H L; Navis G; De Zeeuw D; De Jong P E
Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population.
Journal of the American Society of Nephrology : JASN 2000;11(10):1882-8.
2000: van Paassen P; de Zeeuw D; de Jong P E; Navis G
Renin inhibition improves pressure natriuresis in essential hypertension.
Journal of the American Society of Nephrology : JASN 2000;11(10):1813-8.
2000: Buter H; van Tol A; Navis G J; Scheek L M; de Jong P E; de Zeeuw D; Dullaart R P
Angiotensin II receptor antagonist treatment lowers plasma total and very low + low density lipoprotein cholesterol in Type 1 diabetic patients with albuminuria without affecting plasma cholesterol esterification and cholesteryl ester transfer.
Diabetic medicine : a journal of the British Diabetic Association 2000;17(7):550-2.
2000: van Paassen P; de Zeeuw D; Navis G; de Jong P E
Renal and systemic effects of continued treatment with renin inhibitor remikiren in hypertensive patients with normal and impaired renal function.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2000;15(5):637-43.
2000: Broekroelofs J; Navis G J; Stegeman C A; van der Bij W; de Boer W J; de Zeeuw D; de Jong P E
Long-term renal outcome after lung transplantation is predicted by the 1-month postoperative renal function loss.
Transplantation 2000;69(8):1624-8.
2000: Bos H; Andersen S; Rossing P; De Zeeuw D; Parving H H; De Jong P E; Navis G
Role of patient factors in therapy resistance to antiproteinuric intervention in nondiabetic and diabetic nephropathy.
Kidney international. Supplement 2000;75():S32-7.
2000: Broekroelofs J; Stegeman C A; Navis G J; de Haan J; van der Bij W; de Boer W J; de Zeeuw D; de Jong P E
Creatinine-based estimation of rate of long term renal function loss in lung transplant recipients. Which method is preferable?
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2000;19(3):256-62.
2000: Wapstra F H; Navis G; de Jong P E; de Zeeuw D
Chronic angiotensin II infusion but not bradykinin blockade abolishes the antiproteinuric response to angiotensin-converting enzyme inhibition in established adriamycin nephrosis.
Journal of the American Society of Nephrology : JASN 2000;11(3):490-6.
1999: van Paassen P; Navis G J; De Jong P E; De Zeeuw D
Pretreatment renal vascular tone predicts the effect of specific renin inhibition on natriuresis in essential hypertension.
European journal of clinical investigation 1999;29(12):1019-26.
1999: Navis G; van der Kleij F G; de Zeeuw D; de Jong P E
Angiotensin-converting enzyme gene I/D polymorphism and renal disease.
Journal of molecular medicine (Berlin, Germany) 1999;77(11):781-91.
1999: De Boer E; Navis G; Tiebosch A T; De Jong P E; De Zeeuw D
Systemic factors are involved in the pathogenesis of proteinuria-induced glomerulosclerosis in adriamycin nephrotic rats.
Journal of the American Society of Nephrology : JASN 1999;10(11):2359-66.
1999: Broekroelofs J; Stegeman C A; Navis G; de Jong P E
Prevention of renal function loss after non-renal solid organ transplantation--how can nephrologists help to keep the kidneys out of the line of fire?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(8):1841-3.
1999: de Vries P A; Navis G; de Jong P E; de Zeeuw D; Kluppel C A
Impaired renal vascular response to a D1-like receptor agonist but not to an ACE inhibitor in conscious spontaneously hypertensive rats.
Journal of cardiovascular pharmacology 1999;34(2):191-8.
1999: De Jong P E; Navis G; de Zeeuw D
Renoprotective therapy: titration against urinary protein excretion.
Lancet 1999;354(9176):352-3.
1999: de Boer E; Navis G; Wapstra F H; de Jong P E; de Zeeuw D
Effect of proteinuria reduction on prevention of focal glomerulosclerosis by angiotensin-converting enzyme inhibition is modifiable.
Kidney international. Supplement 1999;71():S42-6.
1999: Wapstra F H; van Goor H; de Jong P E; Navis G; de Zeeuw D
Dose of doxorubicin determines severity of renal damage and responsiveness to ACE-inhibition in experimental nephrosis.
Journal of pharmacological and toxicological methods 1999;41(2-3):69-73.
1999: Buter H; Navis G Y; Woittiez A J; de Zeeuw D; de Jong P E
Pharmacokinetics and pharmacodynamics of candesartan cilexetil in patients with normal to severely impaired renal function.
European journal of clinical pharmacology 1999;54(12):953-8.
1998: Broekroelofs J; Stegeman C A; Navis G; Tegzess A M; De Zeeuw D; De Jong P E
Risk factors for long-term renal survival after renal transplantation: a role for angiotensin-converting enzyme (insertion/deletion) polymorphism?
Journal of the American Society of Nephrology : JASN 1998;9(11):2075-81.
1998: Buter H; Hemmelder M H; Navis G; de Jong P E; de Zeeuw D
The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1998;13(7):1682-5.
1998: Hoogenberg K; Sluiter W J; Navis G; Van Haeften T W; Smit A J; Reitsma W D; Dullaart R P
Exogenous norepinephrine induces an enhanced microproteinuric response in microalbuminuric insulin-dependent diabetes mellitus.
Journal of the American Society of Nephrology : JASN 1998;9(4):643-54.
1998: Broekroelofs J; Navis G; Stegeman C A; van der Bij W; de Jong P E
Lung transplantation.
Lancet 1998;351(9108):1064.
1998: de Vries P A; Navis G; de Jong P E; de Zeeuw D
Can continuous intraperitoneal infusion of 125I-iothalamate and 131I-hippuran be used for measurement of GFR in conscious rats?
Renal failure 1998;20(2):249-55.
1998: Hoogenberg K; Navis G; Dullaart R P
Norepinephrine-induced blood pressure rise and renal vasoconstriction are not attenuated by enalapril treatment in microalbuminuric IDDM.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1998;13(3):640-5.
1998: Koiter J; Navis G; de Jong P E; van Gilst W H; de Zeeuw D
Sample dilution: a methodological pitfall in the measurement of tissue but not serum ace-activity.
Journal of pharmacological and toxicological methods 1998;39(1):45-9.
1997: Buter H; Navis G; de Zeeuw D; de Jong P E
Renal hemodynamic effects of candesartan in normal and impaired renal function in humans.
Kidney international. Supplement 1997;63():S185-7.
1997: van der Kleij F G; Schmidt A; Navis G J; Haas M; Yilmaz N; de Jong P E; Mayer G; de Zeeuw D
Angiotensin converting enzyme insertion/deletion polymorphism and short-term renal response to ACE inhibition: role of sodium status.
Kidney international. Supplement 1997;63():S23-6.
1997: Marcel de Vries P A; Navis G; de Boer E; de Jong P E; de Zeeuw D
A method for accurate measurement of GFR in conscious, spontaneously voiding rats.
Kidney international 1997;52(1):244-7.
1997: Navis G; de Zeeuw D; de Jong P E
ACE-inhibitors: panacea for progressive renal disease.
Lancet 1997;349(9069):1852-3.
1997: Navis G; de Jong P E; de Zeeuw D
I/D polymorphism of the angiotensin converting enzyme gene: a clue to the heterogeneity in the progression of renal disease and in the renal response to therapy?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12(6):1097-100.
1997: Gansevoort R T; Navis G J; Wapstra F H; de Jong P E; de Zeeuw D
Proteinuria and progression of renal disease: therapeutic implications.
Current opinion in nephrology and hypertension 1997;6(2):133-40.
1997: Navis G; de Jong P E; de Zeeuw D
Optimizing the renal response to ace inhibition: a strategy toward more effective long-term renoprotection.
Advances in nephrology from the Necker Hospital 1997;27():57-66.
1997: Buter H; Hemmelder M H; van Paassen P; Navis G; de Zeeuw D; de Jong P E
Is the antiproteinuric response to inhibition of the renin-angiotensin system less effective during the night?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12 Suppl 2():53-6.
1997: van der Kleij F G; Navis G J; Gansevoort R T; Heeg J E; Scheffer H; de Zeeuw D; de Jong P E
ACE polymorphism does not determine short-term renal response to ACE-inhibition in proteinuric patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12 Suppl 2():42-6.
1997: Navis G; Buter H; de Jong P E; Dullaart R P; de Zeeuw D
Effect of antiproteinuric treatment on the lipid profile in nondiabetic renal disease.
Contributions to nephrology 1997;120():88-96.
1996: Navis G; de Zeeuw D
Titrating for antiproteinuric effect: the clue to renoprotection?
Journal of human hypertension 1996;10(10):669-73.
1996: Navis G; Faber H J; de Zeeuw D; de Jong P E
ACE inhibitors and the kidney. A risk-benefit assessment.
Drug safety : an international journal of medical toxicology and drug experience 1996;15(3):200-11.
1996: Visscher C A; De Zeeuw D; Navis G; Van Zanten A K; De Jong P E; Huisman R M
Renal 131I-hippurate clearance overestimates true renal blood flow in the instrumented conscious dog.
The American journal of physiology 1996;271(2 Pt 2):F269-74.
1996: Navis G; Broekroelofs J; Mannes G P; van der Bij W; de Boer W J; Tegzees A M; de Jong P E
Renal hemodynamics after lung transplantation. A prospective study.
Transplantation 1996;61(11):1600-5.
1996: Wapstra F H; Van Goor H; Navis G; De Jong P E; De Zeeuw D
Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established adriamycin nephrosis.
Clinical science (London, England : 1979) 1996;90(5):393-401.
1996: van Paassen P; de Zeeuw D; Navis G; de Jong P E
Does the renin-angiotensin system determine the renal and systemic hemodynamic response to sodium in patients with essential hypertension?
Hypertension 1996;27(2):202-8.
1996: Wapstra F H; Navis G; de Jong P E; de Zeeuw D
Prognostic value of the short-term antiproteinuric response to ACE inhibition for prediction of GFR decline in patients with nondiabetic renal disease.
Experimental nephrology 1996;4 Suppl 1():47-52.
1995: Navis G J; Rommes J H; Baur C; de Jong P E
Transient post-renal obstruction may protect the kidney against nephrotoxic damage--a case report.
Intensive care medicine 1995;21(7):610-1.
1994: Navis G J; Dullaart R P; Vellenga E; Elema J D; de Jong P E
Renal disease in POEMS syndrome: report on a case and review of the literature.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1994;9(10):1477-81.
1993: Oosterhof H; Navis G J; Go J G; Dassel A C; de Jong P E; Aarnoudse J G
Pregnancy in a patient on chronic haemodialysis: fetal monitoring by Doppler velocimetry of the umbilical artery.
British journal of obstetrics and gynaecology 1993;100(12):1140-1.
1989: Navis G J; de Jong P E; de Zeeuw D
Volume homeostasis, angiotensin converting enzyme inhibition, and lithium therapy.
The American journal of medicine 1989;86(5):621.
1987: Navis G; de Jong P; Donker A J; van der Hem G K; de Zeeuw D
Diuretic effects of angiotensin-converting enzyme inhibition: comparison of low and liberal sodium diet in hypertensive patients.
Journal of cardiovascular pharmacology 1987;9(6):743-8.
1987: Navis G; de Jong P E; Donker A J; van der Hem G K; de Zeeuw D
Moderate sodium restriction in hypertensive subjects: renal effects of ACE-inhibition.
Kidney international 1987;31(3):815-9.
1986: Navis G; de Jong P E; van der Hem G K; de Zeeuw D
Renal effects of ketanserin in essential hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1986;4(1):S95-8.
1986: De Jong P E; Navis G J; De Zeeuw D
Atrial natriuretic peptides: a new dimension in the understanding of volume homoeostasis?
The Netherlands journal of medicine 1986;29(5):170-4.
1986: Navis G J; de Zeeuw D; de Jong P E
Enalapril and the kidney: renal vasodilation and natriuresis due to the inhibition of angiotensin II formation.
Journal of cardiovascular pharmacology 1986;8 Suppl 1():S30-4.
1985: Navis G; de Jong P E; Donker A J; van der Hem G K; de Zeeuw D
Effects of enalaprilic acid on sodium excretion and renal hemodynamics in essential hypertension.
Journal of clinical hypertension 1985;1(3):228-38.
1985: Navis G J; de Jong P E; de Zeeuw D
Serum uric acid, ACE inhibitors, and natriuresis.
Lancet 1985;2(8447):156.
1985: Navis G J; de Jong P E; Donker A J; van der Hem G K; de Zeeuw D
Blood pressure response to enalaprilic acid in essential hypertension: dose-response and effect of pre-treatment with furosemide.
European journal of clinical pharmacology 1985;29(1):9-15.
1984: Navis G J; de Jong P E; Kallenberg C G; de Monchy J; de Zeeuw D
Absence of cross-reactivity between captopril and enalapril.
Lancet 1984;1(8384):1017.
1983: de Zeeuw D; Navis G J; Donker A J; de Jong P E
The angiotensin converting enzyme inhibitor enalapril and its effects on renal function.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1983;1(1):93-7.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

gerjan navis

Research Profile (preview)

Anatomy

Chemicals & Drugs

Disorders

Physiology

Living Beings

Phenomena

Concepts & Ideas

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of gerjan navis (preview)

All Publications